Ausgabe 3/2006
Inhalt (10 Artikel)
Editorial
The Unknown Impacts of Combinations of Large Numbers of Drugs
Ronald N. Kostoff, Jeffrey C. Delafuente
Review Article
A Preliminary Benefit-Risk Assessment of Verteporfin in Age-Related Macular Degeneration
Jason Wickens, Kevin J. Blinder
Review Article
Safety and Tolerability of the Antibacterial Rifaximin in the Treatment of Travellers’ Diarrhoea
Charles D. Ericsson
Short Communication
Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
Laurent Uzan, Laurence Guignat, Christophe Meune, Stéphane Mouly, Simon Weber, Xavier Bertagna, Jérôme Bertherat, Pierre Thomopoulos, Denis Duboc
Original Research Article
Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans
Marion Aubert, Rolf Osterwalder, Björn Wagner, Isabelle Parrilla, Icilio Cavero, Lucette Doessegger, Eric A. Ertel
Original Research Article
Early First-Trimester Sibutramine Exposure
Marco De Santis, Gianluca Straface, Anna F. Cavaliere, Brigida Carducci, Alessandro Caruso
Original Research Article
Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan
Weng-Foung Huang, Fei-Yuan Hsiao, Yi-Wen Tsai, Yu-Wen Wen, Yaw-Tang Shih
Correspondence
Extension of Points on Clarifying Terminology in Drug Safety
Manfred Hauben, Lester Reich, Flic Gabbay